Chinese University of Hong Kong: Inflammatory Bowel Diseases trials

The registry lists 13 Inflammatory Bowel Diseases studies with Chinese University of Hong Kong as lead sponsor. 6 are open to participants now and 0 have results posted.

No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Pilot Study on the Efficacy and Safety of a Novel Synbiotic Formula (SGR11) in Patients With Inflammatory Bowel Disease (IBD)Not yet recruitingNCT07411131Not applicable
• Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel DiseaseRecruitingNCT05598489
• Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st CenturyRecruitingNCT04748627
• Biobank - Investigating the Gut Microbiota, Genetics, Epigenetics and MetabolitesRecruitingNCT03855657
• The Fecal Microbiota Transplantation RegistryRecruitingNCT03787771
• GWA Study in Patients With Inflammatory Bowel DiseaseRecruitingNCT01140789
• A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBDStatus unknownNCT04079335
• Tight Control Management in Perianal Crohn's DiseaseStatus unknownNCT03861689Not applicable
• The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut MicrobiotaStatus unknownNCT03462875
• The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMIDCompletedNCT02135289
• Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up StudyCompletedNCT02131168
• Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic DiseaseTerminatedNCT02128503Not applicable
• Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their RelativesTerminatedNCT01140802